Baker Avenue Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10
| Closed | -$1.29K | – | 920 |
|
|
2023
Q3 | $1.29K | Hold |
10
| – | – | ﹤0.01% | 1219 |
|
|
2023
Q2 | $1.24K | Hold |
10
| – | – | ﹤0.01% | 1098 |
|
|
2023
Q1 | $1.46K | Sell |
10
-12
| -55% | -$1.76K | ﹤0.01% | 1059 |
|
|
2022
Q4 | $3.51K | Buy |
+22
| New | +$3.51K | ﹤0.01% | 857 |
|
|
2020
Q1 | – | Sell |
-1,500
| Closed | -$223K | – | 231 |
|
|
2019
Q4 | $223K | Buy |
+1,500
| New | +$223K | 0.02% | 245 |
|
|
2015
Q2 | – | Sell |
-1,440
| Closed | -$249K | – | 258 |
|
|
2015
Q1 | $249K | Sell |
1,440
-60
| -4% | -$10.4K | 0.03% | 199 |
|
|
2014
Q4 | $246K | Buy |
+1,500
| New | +$246K | 0.03% | 232 |
|
|
2014
Q1 | – | Sell |
-1,700
| Closed | -$215K | – | 236 |
|
|
2013
Q4 | $215K | Sell |
1,700
-1,600
| -48% | -$202K | 0.04% | 227 |
|
|
2013
Q3 | $304K | Buy |
+3,300
| New | +$304K | 0.06% | 159 |
|